Global Living Biological Drugs Market Research Report 2025(Status and Outlook)
Living biological drugs, also called live biotherapeutic products (LBPs), are defined as pharmaceutical preparations containing live microorganisms?such as bacteria or yeast?that are administered to prevent, treat, or cure a disease or medical condition by modulating the host?s microbiota or immune response. Unlike traditional small-molecule drugs or biologics derived from non-living components, these therapeutics rely on the viability and metabolic activity of the organisms to exert their therapeutic effects, often through mechanisms like competitive exclusion of pathogens, production of bioactive metabolites, or direct interaction with host cells. They are rigorously characterized, standardized, and manufactured under controlled conditions to ensure purity, potency, and safety, distinguishing them from probiotics, which are generally marketed as dietary supplements and not held to the same regulatory standards for demonstrated clinical efficacy.
The global Living Biological Drugs market size was estimated at USD 530000.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Living Biological Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Living Biological Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Living Biological Drugs market.
Global Living Biological Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience
Market Segmentation (by Type)
Single Strain
Multi Strain
Co-Culture
Market Segmentation (by Application)
Digestive System
Urinary System
Skin System
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Living Biological Drugs Market
Overview of the regional outlook of the Living Biological Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Living Biological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Living Biological Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Living Biological Drugs market size was estimated at USD 530000.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Living Biological Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Living Biological Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Living Biological Drugs market.
Global Living Biological Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ardeypharman
Miyarisan Pharmaceutical
Ferring Pharmaceuticals
Seres Therapeutics
Infant Bacterial Therapeutics
Osel
Takeda
AOBiome
Synlogic
Finch Therapeutics
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Luina Bio
List Labs
MatriSys Bioscience
Market Segmentation (by Type)
Single Strain
Multi Strain
Co-Culture
Market Segmentation (by Application)
Digestive System
Urinary System
Skin System
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Living Biological Drugs Market
Overview of the regional outlook of the Living Biological Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Living Biological Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Living Biological Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Living Biological Drugs
1.2 Key Market Segments
1.2.1 Living Biological Drugs Segment by Type
1.2.2 Living Biological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVING BIOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVING BIOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Living Biological Drugs Product Life Cycle
3.3 Global Living Biological Drugs Revenue Market Share by Company (2020-2025)
3.4 Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Living Biological Drugs Company Headquarters, Area Served, Product Type
3.6 Living Biological Drugs Market Competitive Situation and Trends
3.6.1 Living Biological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Living Biological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVING BIOLOGICAL DRUGS VALUE CHAIN ANALYSIS
4.1 Living Biological Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVING BIOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Living Biological Drugs Market Porter's Five Forces Analysis
6 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Living Biological Drugs Market Size Market Share by Type (2020-2025)
6.3 Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
7 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Living Biological Drugs Market Size (M USD) by Application (2020-2025)
7.3 Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
8 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Living Biological Drugs Market Size by Region
8.1.1 Global Living Biological Drugs Market Size by Region
8.1.2 Global Living Biological Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Living Biological Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Living Biological Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Living Biological Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Living Biological Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Living Biological Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ardeypharman
9.1.1 Ardeypharman Basic Information
9.1.2 Ardeypharman Living Biological Drugs Product Overview
9.1.3 Ardeypharman Living Biological Drugs Product Market Performance
9.1.4 Ardeypharman SWOT Analysis
9.1.5 Ardeypharman Business Overview
9.1.6 Ardeypharman Recent Developments
9.2 Miyarisan Pharmaceutical
9.2.1 Miyarisan Pharmaceutical Basic Information
9.2.2 Miyarisan Pharmaceutical Living Biological Drugs Product Overview
9.2.3 Miyarisan Pharmaceutical Living Biological Drugs Product Market Performance
9.2.4 Miyarisan Pharmaceutical SWOT Analysis
9.2.5 Miyarisan Pharmaceutical Business Overview
9.2.6 Miyarisan Pharmaceutical Recent Developments
9.3 Ferring Pharmaceuticals
9.3.1 Ferring Pharmaceuticals Basic Information
9.3.2 Ferring Pharmaceuticals Living Biological Drugs Product Overview
9.3.3 Ferring Pharmaceuticals Living Biological Drugs Product Market Performance
9.3.4 Ferring Pharmaceuticals SWOT Analysis
9.3.5 Ferring Pharmaceuticals Business Overview
9.3.6 Ferring Pharmaceuticals Recent Developments
9.4 Seres Therapeutics
9.4.1 Seres Therapeutics Basic Information
9.4.2 Seres Therapeutics Living Biological Drugs Product Overview
9.4.3 Seres Therapeutics Living Biological Drugs Product Market Performance
9.4.4 Seres Therapeutics Business Overview
9.4.5 Seres Therapeutics Recent Developments
9.5 Infant Bacterial Therapeutics
9.5.1 Infant Bacterial Therapeutics Basic Information
9.5.2 Infant Bacterial Therapeutics Living Biological Drugs Product Overview
9.5.3 Infant Bacterial Therapeutics Living Biological Drugs Product Market Performance
9.5.4 Infant Bacterial Therapeutics Business Overview
9.5.5 Infant Bacterial Therapeutics Recent Developments
9.6 Osel
9.6.1 Osel Basic Information
9.6.2 Osel Living Biological Drugs Product Overview
9.6.3 Osel Living Biological Drugs Product Market Performance
9.6.4 Osel Business Overview
9.6.5 Osel Recent Developments
9.7 Takeda
9.7.1 Takeda Basic Information
9.7.2 Takeda Living Biological Drugs Product Overview
9.7.3 Takeda Living Biological Drugs Product Market Performance
9.7.4 Takeda Business Overview
9.7.5 Takeda Recent Developments
9.8 AOBiome
9.8.1 AOBiome Basic Information
9.8.2 AOBiome Living Biological Drugs Product Overview
9.8.3 AOBiome Living Biological Drugs Product Market Performance
9.8.4 AOBiome Business Overview
9.8.5 AOBiome Recent Developments
9.9 Synlogic
9.9.1 Synlogic Basic Information
9.9.2 Synlogic Living Biological Drugs Product Overview
9.9.3 Synlogic Living Biological Drugs Product Market Performance
9.9.4 Synlogic Business Overview
9.9.5 Synlogic Recent Developments
9.10 Finch Therapeutics
9.10.1 Finch Therapeutics Basic Information
9.10.2 Finch Therapeutics Living Biological Drugs Product Overview
9.10.3 Finch Therapeutics Living Biological Drugs Product Market Performance
9.10.4 Finch Therapeutics Business Overview
9.10.5 Finch Therapeutics Recent Developments
9.11 Capsugel
9.11.1 Capsugel Basic Information
9.11.2 Capsugel Living Biological Drugs Product Overview
9.11.3 Capsugel Living Biological Drugs Product Market Performance
9.11.4 Capsugel Business Overview
9.11.5 Capsugel Recent Developments
9.12 Jeneil Biotech
9.12.1 Jeneil Biotech Basic Information
9.12.2 Jeneil Biotech Living Biological Drugs Product Overview
9.12.3 Jeneil Biotech Living Biological Drugs Product Market Performance
9.12.4 Jeneil Biotech Business Overview
9.12.5 Jeneil Biotech Recent Developments
9.13 UAS Labs
9.13.1 UAS Labs Basic Information
9.13.2 UAS Labs Living Biological Drugs Product Overview
9.13.3 UAS Labs Living Biological Drugs Product Market Performance
9.13.4 UAS Labs Business Overview
9.13.5 UAS Labs Recent Developments
9.14 Biose
9.14.1 Biose Basic Information
9.14.2 Biose Living Biological Drugs Product Overview
9.14.3 Biose Living Biological Drugs Product Market Performance
9.14.4 Biose Business Overview
9.14.5 Biose Recent Developments
9.15 Cerbios-Pharma
9.15.1 Cerbios-Pharma Basic Information
9.15.2 Cerbios-Pharma Living Biological Drugs Product Overview
9.15.3 Cerbios-Pharma Living Biological Drugs Product Market Performance
9.15.4 Cerbios-Pharma Business Overview
9.15.5 Cerbios-Pharma Recent Developments
9.16 Inpac Probiotics
9.16.1 Inpac Probiotics Basic Information
9.16.2 Inpac Probiotics Living Biological Drugs Product Overview
9.16.3 Inpac Probiotics Living Biological Drugs Product Market Performance
9.16.4 Inpac Probiotics Business Overview
9.16.5 Inpac Probiotics Recent Developments
9.17 NIZO
9.17.1 NIZO Basic Information
9.17.2 NIZO Living Biological Drugs Product Overview
9.17.3 NIZO Living Biological Drugs Product Market Performance
9.17.4 NIZO Business Overview
9.17.5 NIZO Recent Developments
9.18 Winclove Probiotics
9.18.1 Winclove Probiotics Basic Information
9.18.2 Winclove Probiotics Living Biological Drugs Product Overview
9.18.3 Winclove Probiotics Living Biological Drugs Product Market Performance
9.18.4 Winclove Probiotics Business Overview
9.18.5 Winclove Probiotics Recent Developments
9.19 BJP Laboratories
9.19.1 BJP Laboratories Basic Information
9.19.2 BJP Laboratories Living Biological Drugs Product Overview
9.19.3 BJP Laboratories Living Biological Drugs Product Market Performance
9.19.4 BJP Laboratories Business Overview
9.19.5 BJP Laboratories Recent Developments
9.20 Luina Bio
9.20.1 Luina Bio Basic Information
9.20.2 Luina Bio Living Biological Drugs Product Overview
9.20.3 Luina Bio Living Biological Drugs Product Market Performance
9.20.4 Luina Bio Business Overview
9.20.5 Luina Bio Recent Developments
9.21 List Labs
9.21.1 List Labs Basic Information
9.21.2 List Labs Living Biological Drugs Product Overview
9.21.3 List Labs Living Biological Drugs Product Market Performance
9.21.4 List Labs Business Overview
9.21.5 List Labs Recent Developments
9.22 MatriSys Bioscience
9.22.1 MatriSys Bioscience Basic Information
9.22.2 MatriSys Bioscience Living Biological Drugs Product Overview
9.22.3 MatriSys Bioscience Living Biological Drugs Product Market Performance
9.22.4 MatriSys Bioscience Business Overview
9.22.5 MatriSys Bioscience Recent Developments
10 LIVING BIOLOGICAL DRUGS MARKET FORECAST BY REGION
10.1 Global Living Biological Drugs Market Size Forecast
10.2 Global Living Biological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Living Biological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Living Biological Drugs Market Size Forecast by Region
10.2.4 South America Living Biological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Living Biological Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Living Biological Drugs Market Forecast by Type (2026-2033)
11.2 Global Living Biological Drugs Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Living Biological Drugs
1.2 Key Market Segments
1.2.1 Living Biological Drugs Segment by Type
1.2.2 Living Biological Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LIVING BIOLOGICAL DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LIVING BIOLOGICAL DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Living Biological Drugs Product Life Cycle
3.3 Global Living Biological Drugs Revenue Market Share by Company (2020-2025)
3.4 Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Living Biological Drugs Company Headquarters, Area Served, Product Type
3.6 Living Biological Drugs Market Competitive Situation and Trends
3.6.1 Living Biological Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Living Biological Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 LIVING BIOLOGICAL DRUGS VALUE CHAIN ANALYSIS
4.1 Living Biological Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LIVING BIOLOGICAL DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Living Biological Drugs Market Porter's Five Forces Analysis
6 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Living Biological Drugs Market Size Market Share by Type (2020-2025)
6.3 Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
7 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Living Biological Drugs Market Size (M USD) by Application (2020-2025)
7.3 Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
8 LIVING BIOLOGICAL DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Living Biological Drugs Market Size by Region
8.1.1 Global Living Biological Drugs Market Size by Region
8.1.2 Global Living Biological Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Living Biological Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Living Biological Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Living Biological Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Living Biological Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Living Biological Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ardeypharman
9.1.1 Ardeypharman Basic Information
9.1.2 Ardeypharman Living Biological Drugs Product Overview
9.1.3 Ardeypharman Living Biological Drugs Product Market Performance
9.1.4 Ardeypharman SWOT Analysis
9.1.5 Ardeypharman Business Overview
9.1.6 Ardeypharman Recent Developments
9.2 Miyarisan Pharmaceutical
9.2.1 Miyarisan Pharmaceutical Basic Information
9.2.2 Miyarisan Pharmaceutical Living Biological Drugs Product Overview
9.2.3 Miyarisan Pharmaceutical Living Biological Drugs Product Market Performance
9.2.4 Miyarisan Pharmaceutical SWOT Analysis
9.2.5 Miyarisan Pharmaceutical Business Overview
9.2.6 Miyarisan Pharmaceutical Recent Developments
9.3 Ferring Pharmaceuticals
9.3.1 Ferring Pharmaceuticals Basic Information
9.3.2 Ferring Pharmaceuticals Living Biological Drugs Product Overview
9.3.3 Ferring Pharmaceuticals Living Biological Drugs Product Market Performance
9.3.4 Ferring Pharmaceuticals SWOT Analysis
9.3.5 Ferring Pharmaceuticals Business Overview
9.3.6 Ferring Pharmaceuticals Recent Developments
9.4 Seres Therapeutics
9.4.1 Seres Therapeutics Basic Information
9.4.2 Seres Therapeutics Living Biological Drugs Product Overview
9.4.3 Seres Therapeutics Living Biological Drugs Product Market Performance
9.4.4 Seres Therapeutics Business Overview
9.4.5 Seres Therapeutics Recent Developments
9.5 Infant Bacterial Therapeutics
9.5.1 Infant Bacterial Therapeutics Basic Information
9.5.2 Infant Bacterial Therapeutics Living Biological Drugs Product Overview
9.5.3 Infant Bacterial Therapeutics Living Biological Drugs Product Market Performance
9.5.4 Infant Bacterial Therapeutics Business Overview
9.5.5 Infant Bacterial Therapeutics Recent Developments
9.6 Osel
9.6.1 Osel Basic Information
9.6.2 Osel Living Biological Drugs Product Overview
9.6.3 Osel Living Biological Drugs Product Market Performance
9.6.4 Osel Business Overview
9.6.5 Osel Recent Developments
9.7 Takeda
9.7.1 Takeda Basic Information
9.7.2 Takeda Living Biological Drugs Product Overview
9.7.3 Takeda Living Biological Drugs Product Market Performance
9.7.4 Takeda Business Overview
9.7.5 Takeda Recent Developments
9.8 AOBiome
9.8.1 AOBiome Basic Information
9.8.2 AOBiome Living Biological Drugs Product Overview
9.8.3 AOBiome Living Biological Drugs Product Market Performance
9.8.4 AOBiome Business Overview
9.8.5 AOBiome Recent Developments
9.9 Synlogic
9.9.1 Synlogic Basic Information
9.9.2 Synlogic Living Biological Drugs Product Overview
9.9.3 Synlogic Living Biological Drugs Product Market Performance
9.9.4 Synlogic Business Overview
9.9.5 Synlogic Recent Developments
9.10 Finch Therapeutics
9.10.1 Finch Therapeutics Basic Information
9.10.2 Finch Therapeutics Living Biological Drugs Product Overview
9.10.3 Finch Therapeutics Living Biological Drugs Product Market Performance
9.10.4 Finch Therapeutics Business Overview
9.10.5 Finch Therapeutics Recent Developments
9.11 Capsugel
9.11.1 Capsugel Basic Information
9.11.2 Capsugel Living Biological Drugs Product Overview
9.11.3 Capsugel Living Biological Drugs Product Market Performance
9.11.4 Capsugel Business Overview
9.11.5 Capsugel Recent Developments
9.12 Jeneil Biotech
9.12.1 Jeneil Biotech Basic Information
9.12.2 Jeneil Biotech Living Biological Drugs Product Overview
9.12.3 Jeneil Biotech Living Biological Drugs Product Market Performance
9.12.4 Jeneil Biotech Business Overview
9.12.5 Jeneil Biotech Recent Developments
9.13 UAS Labs
9.13.1 UAS Labs Basic Information
9.13.2 UAS Labs Living Biological Drugs Product Overview
9.13.3 UAS Labs Living Biological Drugs Product Market Performance
9.13.4 UAS Labs Business Overview
9.13.5 UAS Labs Recent Developments
9.14 Biose
9.14.1 Biose Basic Information
9.14.2 Biose Living Biological Drugs Product Overview
9.14.3 Biose Living Biological Drugs Product Market Performance
9.14.4 Biose Business Overview
9.14.5 Biose Recent Developments
9.15 Cerbios-Pharma
9.15.1 Cerbios-Pharma Basic Information
9.15.2 Cerbios-Pharma Living Biological Drugs Product Overview
9.15.3 Cerbios-Pharma Living Biological Drugs Product Market Performance
9.15.4 Cerbios-Pharma Business Overview
9.15.5 Cerbios-Pharma Recent Developments
9.16 Inpac Probiotics
9.16.1 Inpac Probiotics Basic Information
9.16.2 Inpac Probiotics Living Biological Drugs Product Overview
9.16.3 Inpac Probiotics Living Biological Drugs Product Market Performance
9.16.4 Inpac Probiotics Business Overview
9.16.5 Inpac Probiotics Recent Developments
9.17 NIZO
9.17.1 NIZO Basic Information
9.17.2 NIZO Living Biological Drugs Product Overview
9.17.3 NIZO Living Biological Drugs Product Market Performance
9.17.4 NIZO Business Overview
9.17.5 NIZO Recent Developments
9.18 Winclove Probiotics
9.18.1 Winclove Probiotics Basic Information
9.18.2 Winclove Probiotics Living Biological Drugs Product Overview
9.18.3 Winclove Probiotics Living Biological Drugs Product Market Performance
9.18.4 Winclove Probiotics Business Overview
9.18.5 Winclove Probiotics Recent Developments
9.19 BJP Laboratories
9.19.1 BJP Laboratories Basic Information
9.19.2 BJP Laboratories Living Biological Drugs Product Overview
9.19.3 BJP Laboratories Living Biological Drugs Product Market Performance
9.19.4 BJP Laboratories Business Overview
9.19.5 BJP Laboratories Recent Developments
9.20 Luina Bio
9.20.1 Luina Bio Basic Information
9.20.2 Luina Bio Living Biological Drugs Product Overview
9.20.3 Luina Bio Living Biological Drugs Product Market Performance
9.20.4 Luina Bio Business Overview
9.20.5 Luina Bio Recent Developments
9.21 List Labs
9.21.1 List Labs Basic Information
9.21.2 List Labs Living Biological Drugs Product Overview
9.21.3 List Labs Living Biological Drugs Product Market Performance
9.21.4 List Labs Business Overview
9.21.5 List Labs Recent Developments
9.22 MatriSys Bioscience
9.22.1 MatriSys Bioscience Basic Information
9.22.2 MatriSys Bioscience Living Biological Drugs Product Overview
9.22.3 MatriSys Bioscience Living Biological Drugs Product Market Performance
9.22.4 MatriSys Bioscience Business Overview
9.22.5 MatriSys Bioscience Recent Developments
10 LIVING BIOLOGICAL DRUGS MARKET FORECAST BY REGION
10.1 Global Living Biological Drugs Market Size Forecast
10.2 Global Living Biological Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Living Biological Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Living Biological Drugs Market Size Forecast by Region
10.2.4 South America Living Biological Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Living Biological Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Living Biological Drugs Market Forecast by Type (2026-2033)
11.2 Global Living Biological Drugs Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Living Biological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Living Biological Drugs Revenue (M USD) by Company (2020-2025)
Table 6. Global Living Biological Drugs Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2024)
Table 8. Living Biological Drugs Company Headquarters and Area Served
Table 9. Company Living Biological Drugs Product Type
Table 10. Global Living Biological Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Living Biological Drugs Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Living Biological Drugs Market Size by Type (M USD)
Table 21. Global Living Biological Drugs Market Size (M USD) by Type (2020-2025)
Table 22. Global Living Biological Drugs Market Size Share by Type (2020-2025)
Table 23. Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
Table 24. Global Living Biological Drugs Market Size by Application
Table 25. Global Living Biological Drugs Market Size by Application (2020-2025) & (M USD)
Table 26. Global Living Biological Drugs Market Share by Application (2020-2025)
Table 27. Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
Table 28. Global Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 29. Global Living Biological Drugs Market Size Market Share by Region (2020-2025)
Table 30. North America Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 33. South America Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 35. Ardeypharman Basic Information
Table 36. Ardeypharman Living Biological Drugs Product Overview
Table 37. Ardeypharman Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Ardeypharman SWOT Analysis
Table 39. Ardeypharman Business Overview
Table 40. Ardeypharman Recent Developments
Table 41. Miyarisan Pharmaceutical Basic Information
Table 42. Miyarisan Pharmaceutical Living Biological Drugs Product Overview
Table 43. Miyarisan Pharmaceutical Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Miyarisan Pharmaceutical SWOT Analysis
Table 45. Miyarisan Pharmaceutical Business Overview
Table 46. Miyarisan Pharmaceutical Recent Developments
Table 47. Ferring Pharmaceuticals Basic Information
Table 48. Ferring Pharmaceuticals Living Biological Drugs Product Overview
Table 49. Ferring Pharmaceuticals Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Ferring Pharmaceuticals SWOT Analysis
Table 51. Ferring Pharmaceuticals Business Overview
Table 52. Ferring Pharmaceuticals Recent Developments
Table 53. Seres Therapeutics Basic Information
Table 54. Seres Therapeutics Living Biological Drugs Product Overview
Table 55. Seres Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Seres Therapeutics Business Overview
Table 57. Seres Therapeutics Recent Developments
Table 58. Infant Bacterial Therapeutics Basic Information
Table 59. Infant Bacterial Therapeutics Living Biological Drugs Product Overview
Table 60. Infant Bacterial Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Infant Bacterial Therapeutics Business Overview
Table 62. Infant Bacterial Therapeutics Recent Developments
Table 63. Osel Basic Information
Table 64. Osel Living Biological Drugs Product Overview
Table 65. Osel Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Osel Business Overview
Table 67. Osel Recent Developments
Table 68. Takeda Basic Information
Table 69. Takeda Living Biological Drugs Product Overview
Table 70. Takeda Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Takeda Business Overview
Table 72. Takeda Recent Developments
Table 73. AOBiome Basic Information
Table 74. AOBiome Living Biological Drugs Product Overview
Table 75. AOBiome Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 76. AOBiome Business Overview
Table 77. AOBiome Recent Developments
Table 78. Synlogic Basic Information
Table 79. Synlogic Living Biological Drugs Product Overview
Table 80. Synlogic Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Synlogic Business Overview
Table 82. Synlogic Recent Developments
Table 83. Finch Therapeutics Basic Information
Table 84. Finch Therapeutics Living Biological Drugs Product Overview
Table 85. Finch Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Finch Therapeutics Business Overview
Table 87. Finch Therapeutics Recent Developments
Table 88. Capsugel Basic Information
Table 89. Capsugel Living Biological Drugs Product Overview
Table 90. Capsugel Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Capsugel Business Overview
Table 92. Capsugel Recent Developments
Table 93. Jeneil Biotech Basic Information
Table 94. Jeneil Biotech Living Biological Drugs Product Overview
Table 95. Jeneil Biotech Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Jeneil Biotech Business Overview
Table 97. Jeneil Biotech Recent Developments
Table 98. UAS Labs Basic Information
Table 99. UAS Labs Living Biological Drugs Product Overview
Table 100. UAS Labs Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 101. UAS Labs Business Overview
Table 102. UAS Labs Recent Developments
Table 103. Biose Basic Information
Table 104. Biose Living Biological Drugs Product Overview
Table 105. Biose Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Biose Business Overview
Table 107. Biose Recent Developments
Table 108. Cerbios-Pharma Basic Information
Table 109. Cerbios-Pharma Living Biological Drugs Product Overview
Table 110. Cerbios-Pharma Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Cerbios-Pharma Business Overview
Table 112. Cerbios-Pharma Recent Developments
Table 113. Inpac Probiotics Basic Information
Table 114. Inpac Probiotics Living Biological Drugs Product Overview
Table 115. Inpac Probiotics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Inpac Probiotics Business Overview
Table 117. Inpac Probiotics Recent Developments
Table 118. NIZO Basic Information
Table 119. NIZO Living Biological Drugs Product Overview
Table 120. NIZO Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 121. NIZO Business Overview
Table 122. NIZO Recent Developments
Table 123. Winclove Probiotics Basic Information
Table 124. Winclove Probiotics Living Biological Drugs Product Overview
Table 125. Winclove Probiotics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Winclove Probiotics Business Overview
Table 127. Winclove Probiotics Recent Developments
Table 128. BJP Laboratories Basic Information
Table 129. BJP Laboratories Living Biological Drugs Product Overview
Table 130. BJP Laboratories Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 131. BJP Laboratories Business Overview
Table 132. BJP Laboratories Recent Developments
Table 133. Luina Bio Basic Information
Table 134. Luina Bio Living Biological Drugs Product Overview
Table 135. Luina Bio Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Luina Bio Business Overview
Table 137. Luina Bio Recent Developments
Table 138. List Labs Basic Information
Table 139. List Labs Living Biological Drugs Product Overview
Table 140. List Labs Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 141. List Labs Business Overview
Table 142. List Labs Recent Developments
Table 143. MatriSys Bioscience Basic Information
Table 144. MatriSys Bioscience Living Biological Drugs Product Overview
Table 145. MatriSys Bioscience Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 146. MatriSys Bioscience Business Overview
Table 147. MatriSys Bioscience Recent Developments
Table 148. Global Living Biological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 149. North America Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Europe Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Asia Pacific Living Biological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Global Living Biological Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 155. Global Living Biological Drugs Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Living Biological Drugs Market Size Comparison by Region (M USD)
Table 5. Global Living Biological Drugs Revenue (M USD) by Company (2020-2025)
Table 6. Global Living Biological Drugs Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Living Biological Drugs as of 2024)
Table 8. Living Biological Drugs Company Headquarters and Area Served
Table 9. Company Living Biological Drugs Product Type
Table 10. Global Living Biological Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Living Biological Drugs Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Living Biological Drugs Market Size by Type (M USD)
Table 21. Global Living Biological Drugs Market Size (M USD) by Type (2020-2025)
Table 22. Global Living Biological Drugs Market Size Share by Type (2020-2025)
Table 23. Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
Table 24. Global Living Biological Drugs Market Size by Application
Table 25. Global Living Biological Drugs Market Size by Application (2020-2025) & (M USD)
Table 26. Global Living Biological Drugs Market Share by Application (2020-2025)
Table 27. Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
Table 28. Global Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 29. Global Living Biological Drugs Market Size Market Share by Region (2020-2025)
Table 30. North America Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 33. South America Living Biological Drugs Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Living Biological Drugs Market Size by Region (2020-2025) & (M USD)
Table 35. Ardeypharman Basic Information
Table 36. Ardeypharman Living Biological Drugs Product Overview
Table 37. Ardeypharman Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 38. Ardeypharman SWOT Analysis
Table 39. Ardeypharman Business Overview
Table 40. Ardeypharman Recent Developments
Table 41. Miyarisan Pharmaceutical Basic Information
Table 42. Miyarisan Pharmaceutical Living Biological Drugs Product Overview
Table 43. Miyarisan Pharmaceutical Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Miyarisan Pharmaceutical SWOT Analysis
Table 45. Miyarisan Pharmaceutical Business Overview
Table 46. Miyarisan Pharmaceutical Recent Developments
Table 47. Ferring Pharmaceuticals Basic Information
Table 48. Ferring Pharmaceuticals Living Biological Drugs Product Overview
Table 49. Ferring Pharmaceuticals Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 50. Ferring Pharmaceuticals SWOT Analysis
Table 51. Ferring Pharmaceuticals Business Overview
Table 52. Ferring Pharmaceuticals Recent Developments
Table 53. Seres Therapeutics Basic Information
Table 54. Seres Therapeutics Living Biological Drugs Product Overview
Table 55. Seres Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Seres Therapeutics Business Overview
Table 57. Seres Therapeutics Recent Developments
Table 58. Infant Bacterial Therapeutics Basic Information
Table 59. Infant Bacterial Therapeutics Living Biological Drugs Product Overview
Table 60. Infant Bacterial Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Infant Bacterial Therapeutics Business Overview
Table 62. Infant Bacterial Therapeutics Recent Developments
Table 63. Osel Basic Information
Table 64. Osel Living Biological Drugs Product Overview
Table 65. Osel Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Osel Business Overview
Table 67. Osel Recent Developments
Table 68. Takeda Basic Information
Table 69. Takeda Living Biological Drugs Product Overview
Table 70. Takeda Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Takeda Business Overview
Table 72. Takeda Recent Developments
Table 73. AOBiome Basic Information
Table 74. AOBiome Living Biological Drugs Product Overview
Table 75. AOBiome Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 76. AOBiome Business Overview
Table 77. AOBiome Recent Developments
Table 78. Synlogic Basic Information
Table 79. Synlogic Living Biological Drugs Product Overview
Table 80. Synlogic Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Synlogic Business Overview
Table 82. Synlogic Recent Developments
Table 83. Finch Therapeutics Basic Information
Table 84. Finch Therapeutics Living Biological Drugs Product Overview
Table 85. Finch Therapeutics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Finch Therapeutics Business Overview
Table 87. Finch Therapeutics Recent Developments
Table 88. Capsugel Basic Information
Table 89. Capsugel Living Biological Drugs Product Overview
Table 90. Capsugel Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Capsugel Business Overview
Table 92. Capsugel Recent Developments
Table 93. Jeneil Biotech Basic Information
Table 94. Jeneil Biotech Living Biological Drugs Product Overview
Table 95. Jeneil Biotech Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Jeneil Biotech Business Overview
Table 97. Jeneil Biotech Recent Developments
Table 98. UAS Labs Basic Information
Table 99. UAS Labs Living Biological Drugs Product Overview
Table 100. UAS Labs Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 101. UAS Labs Business Overview
Table 102. UAS Labs Recent Developments
Table 103. Biose Basic Information
Table 104. Biose Living Biological Drugs Product Overview
Table 105. Biose Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Biose Business Overview
Table 107. Biose Recent Developments
Table 108. Cerbios-Pharma Basic Information
Table 109. Cerbios-Pharma Living Biological Drugs Product Overview
Table 110. Cerbios-Pharma Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Cerbios-Pharma Business Overview
Table 112. Cerbios-Pharma Recent Developments
Table 113. Inpac Probiotics Basic Information
Table 114. Inpac Probiotics Living Biological Drugs Product Overview
Table 115. Inpac Probiotics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Inpac Probiotics Business Overview
Table 117. Inpac Probiotics Recent Developments
Table 118. NIZO Basic Information
Table 119. NIZO Living Biological Drugs Product Overview
Table 120. NIZO Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 121. NIZO Business Overview
Table 122. NIZO Recent Developments
Table 123. Winclove Probiotics Basic Information
Table 124. Winclove Probiotics Living Biological Drugs Product Overview
Table 125. Winclove Probiotics Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Winclove Probiotics Business Overview
Table 127. Winclove Probiotics Recent Developments
Table 128. BJP Laboratories Basic Information
Table 129. BJP Laboratories Living Biological Drugs Product Overview
Table 130. BJP Laboratories Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 131. BJP Laboratories Business Overview
Table 132. BJP Laboratories Recent Developments
Table 133. Luina Bio Basic Information
Table 134. Luina Bio Living Biological Drugs Product Overview
Table 135. Luina Bio Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Luina Bio Business Overview
Table 137. Luina Bio Recent Developments
Table 138. List Labs Basic Information
Table 139. List Labs Living Biological Drugs Product Overview
Table 140. List Labs Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 141. List Labs Business Overview
Table 142. List Labs Recent Developments
Table 143. MatriSys Bioscience Basic Information
Table 144. MatriSys Bioscience Living Biological Drugs Product Overview
Table 145. MatriSys Bioscience Living Biological Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 146. MatriSys Bioscience Business Overview
Table 147. MatriSys Bioscience Recent Developments
Table 148. Global Living Biological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 149. North America Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Europe Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 151. Asia Pacific Living Biological Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Living Biological Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Global Living Biological Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 155. Global Living Biological Drugs Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Living Biological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Living Biological Drugs Market Size (M USD), 2024-2033
Figure 5. Global Living Biological Drugs Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Living Biological Drugs Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Living Biological Drugs Product Life Cycle
Figure 12. Global Living Biological Drugs Revenue Share by Company in 2024
Figure 13. Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Living Biological Drugs Revenue in 2024
Figure 15. Value Chain Map of Living Biological Drugs
Figure 16. Global Living Biological Drugs Market PEST Analysis
Figure 17. Global Living Biological Drugs Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Living Biological Drugs Market Share by Type
Figure 20. Market Size Share of Living Biological Drugs by Type (2020-2025)
Figure 21. Market Size Share of Living Biological Drugs by Type in 2024
Figure 22. Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Living Biological Drugs Market Share by Application
Figure 25. Global Living Biological Drugs Market Share by Application (2020-2025)
Figure 26. Global Living Biological Drugs Market Share by Application in 2024
Figure 27. Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
Figure 28. Global Living Biological Drugs Market Size Market Share by Region (2020-2025)
Figure 29. North America Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Living Biological Drugs Market Size Market Share by Country in 2024
Figure 31. U.S. Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Living Biological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Living Biological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Living Biological Drugs Market Share by Country in 2024
Figure 36. Germany Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Living Biological Drugs Market Size Market Share by Region in 2024
Figure 43. China Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 49. South America Living Biological Drugs Market Size Market Share by Country in 2024
Figure 50. Brazil Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Living Biological Drugs Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Living Biological Drugs Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Living Biological Drugs Market Share Forecast by Type (2026-2033)
Figure 62. Global Living Biological Drugs Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Living Biological Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Living Biological Drugs Market Size (M USD), 2024-2033
Figure 5. Global Living Biological Drugs Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Living Biological Drugs Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Living Biological Drugs Product Life Cycle
Figure 12. Global Living Biological Drugs Revenue Share by Company in 2024
Figure 13. Living Biological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Living Biological Drugs Revenue in 2024
Figure 15. Value Chain Map of Living Biological Drugs
Figure 16. Global Living Biological Drugs Market PEST Analysis
Figure 17. Global Living Biological Drugs Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Living Biological Drugs Market Share by Type
Figure 20. Market Size Share of Living Biological Drugs by Type (2020-2025)
Figure 21. Market Size Share of Living Biological Drugs by Type in 2024
Figure 22. Global Living Biological Drugs Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Living Biological Drugs Market Share by Application
Figure 25. Global Living Biological Drugs Market Share by Application (2020-2025)
Figure 26. Global Living Biological Drugs Market Share by Application in 2024
Figure 27. Global Living Biological Drugs Sales Growth Rate by Application (2020-2025)
Figure 28. Global Living Biological Drugs Market Size Market Share by Region (2020-2025)
Figure 29. North America Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Living Biological Drugs Market Size Market Share by Country in 2024
Figure 31. U.S. Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Living Biological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Living Biological Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Living Biological Drugs Market Share by Country in 2024
Figure 36. Germany Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Living Biological Drugs Market Size Market Share by Region in 2024
Figure 43. China Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 49. South America Living Biological Drugs Market Size Market Share by Country in 2024
Figure 50. Brazil Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Living Biological Drugs Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Living Biological Drugs Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Living Biological Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Living Biological Drugs Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Living Biological Drugs Market Share Forecast by Type (2026-2033)
Figure 62. Global Living Biological Drugs Market Share Forecast by Application (2026-2033)
More Publications
Global Vehicular Military Antennas Market Research Report 2025(Status and Outlook)
US$ 3,200.00
September 2025
154 pages
Global Intelligent Traffic Cameras Market Research Report 2024(Status and Outlook)
US$ 2,800.00
April 2024
136 pages
Global Large Area Displays Market Research Report 2024(Status and Outlook)
US$ 2,800.00
April 2024
132 pages
Global CMP Wafer Retaining Rings Market Research Report 2026(Status and Outlook)
US$ 2,980.00
March 2026
142 pages
Global Smart Voice and Speech Recognition Market Research Report 2026(Status and Outlook)
US$ 2,800.00
June 2026
115 pages
